Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 Jagsonpal Pharmaceuticals has informed that it enclosed Voting results of the 44th AGM held on Thursday, August 31, 2023 through Video Conferencing/Other Audio-Visual Means (‘VC/OAVM') along with Scrutinizer Report dated August 31, 2023 pursuant to Companies Act, 2013 and Rules made thereunder.
The above information is a part of company’s filings submitted to BSE.